| AWK |
Report |
Operating EPS (Q2 2026) |
BEAT |
pred ~$1.57 vs. cons $1.545 |
MEDIUM |
| AWK |
Report |
Operating Revenues (Q2 2026) |
MISS |
pred ~$1.30B vs. cons $1.313B |
MEDIUM |
| AWK |
Report |
Regulated O&M (Q2 2026) |
MISS |
pred ~$418M vs. cons $413M |
MEDIUM |
| AWK |
Guide |
FY 2026 Operating EPS (FY 2026) |
UNCHANGED |
guide ~$6.02-$6.12 reaffirmed vs. cons $6.090 |
HIGH |
| AWK |
Guide |
H2 Revenue Ramp / PA Rate Commentary (Q3-Q4 2026) |
UNCHANGED |
reaffirm PA Aug + NJ fall; flag $74.9M PA outcome as within plan |
MEDIUM |
| AWK |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.2% |
— |
MEDIUM |
| AWK |
Return |
5-day cumulative residual |
-2.0% (FADE) |
FADE — sell-side incorporates PA shortfall into Q3/Q4 estimates; partial offset from low bar and HTO positive read |
MEDIUM |